- Halitosis treatments, including therapeutic mouthwashes, antiseptic rinses, and antimicrobial toothpaste, are increasingly vital components of modern oral healthcare due to their effectiveness in addressing both temporary and chronic bad breath in residential and clinical settings
- The escalating demand for halitosis treatments is primarily fueled by rising awareness of oral hygiene, increasing incidences of periodontal diseases, and a growing preference for non-invasive solutions to improve social and professional interactions
- North America dominated the halitosis treatment market with the largest revenue share of 43.2% in 2024, characterized by early adoption of advanced oral care solutions, high disposable incomes, and a strong presence of key industry players. The U.S. experienced substantial growth in halitosis treatment adoption across pharmacies and dental clinics, driven by increased awareness campaigns and innovations in formulation by established and emerging brands
- Asia-Pacific is expected to be the fastest growing region in the halitosis treatment market during the forecast period, with a projected CAGR of 24.3%, due to increasing urbanization, rising disposable incomes, and growing awareness of oral health in countries such as China, India, and Japan
- The halimeter segment dominated the halitosis treatment market under the diagnostic tests category with a market share of 36.7% in 2024, driven by its accuracy in detecting volatile sulfur compounds (VSCs), which are key indicators of bad breath
